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Cardiovascular disease is the leading cause of death worldwide. Advanced insights 
into disease mechanisms and therapeutic strategies require a deeper understanding 
of the molecular processes involved in the healthy heart. Knowledge of the full 
repertoire of cardiac cells and their gene expression profiles is a fundamental first step 
in this endeavour. Here, using state-of-the-art analyses of large-scale single-cell and 
single-nucleus transcriptomes, we characterize six anatomical adult heart regions. 
Our results highlight the cellular heterogeneity of cardiomyocytes, pericytes and 
fibroblasts, and reveal distinct atrial and ventricular subsets of cells with diverse 
developmental origins and specialized properties. We define the complexity of the 
cardiac vasculature and its changes along the arterio-venous axis. In the immune 
compartment, we identify cardiac-resident macrophages with inflammatory and 
protective transcriptional signatures. Furthermore, analyses of cell-to-cell 
interactions highlight different networks of macrophages, fibroblasts and 
cardiomyocytes between atria and ventricles that are distinct from those of skeletal 
muscle. Our human cardiac cell atlas improves our understanding of the human heart 
and provides a valuable reference for future studies.
The heart is a complex organ, composed of four morphologically and 
functionally distinct chambers (Fig. 1a). Deoxygenated blood from the 
low-pressure right atrium and ventricle is propelled into the lungs. Oxy-
genated blood enters the left atrium and ventricle, which propels blood 
across the body at systemic pressure. Chambers are separated by the 
interatrial and interventricular septa, and unidirectional flow is estab-
lished by the atrio-ventricular and ventricular-arterial valves. An intrinsic 
electrophysiological system rapidly propagates electrical impulses 
from the sinoatrial node to the atrioventricular node, and along Purkinje 
fibres to the apex where contraction begins. Cardiac anatomical and 
functional complexity requires exquisite orchestration of heterogeneous 
cell populations to enable continuous contraction and relaxation across 
different pressures, strains and biophysical stimuli in each chamber.
The heart is derived from multipotent progenitor cells that com-
prise two heart fields. Cells of the first heart field primarily populate 
the left ventricle; second heart field cells populate the right ventricle, 
and both fields contribute to the atria. Haemodynamics changes in 
the postnatal period and the distinct gene regulatory networks that 
operate in each heart field presumably prime gene expression patterns 
of adult heart cells1.
Single-cell and single-nucleus RNA sequencing (scRNA-seq and 
snRNA-seq, respectively) and multiplex single-molecule fluorescence 
in situ hybridization (smFISH) enable the identification of anatomical 
specificities, molecular signatures, intercellular networks and spatial 
relationships by illuminating the coordinated communication of car-
diac cells within their microenvironments2.
We present comprehensive transcriptomic data on six distinct car-
diac regions, providing, to our knowledge, the largest reference frame-
work so far3,4. We incorporate snRNA-seq to ensure high-throughput 
capture of large cardiomyocytes (length and width approximately 
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100 and 25 μm) and scRNA-seq to upsample and enrich endothelial and 
immune cell populations. Using multiplex smFISH imaging, we describe 
the spatial distribution of selected cell populations and cell–cell 
co-localizations. We compare cardiac cell and nuclear transcriptomes 
with those of skeletal muscle and kidney, highlighting cardiac-specific 
cell signatures. Our study defines the cellular and molecular signatures 
of the adult healthy heart, and enables functional plasticity in response 
to varying physiological conditions and diseases.
Cellular landscape of the adult human heart
We isolate single cells, nuclei and CD45+ enriched cells from the left and 
right ventricular free walls, left and right atrium, the left ventricular 
apex, and interventricular septum, from 14 adults (Fig. 1a, b, Supple-
mentary Table 1). After processing with 10X Genomics and a generative 
deep variational autoencoder, the resulting dataset comprises 45,870 
cells, 78,023 CD45+ enriched cells and 363,213 nuclei for 11 major cell 
types: atrial cardiomyocytes, ventricular cardiomyocytes, fibroblasts 
(FBs), endothelial cells (ECs), pericytes, smooth muscle cells (SMCs), 
immune cells (myeloid and lymphoid), adipocytes, mesothelial cells 
and neuronal cells (Fig. 1c, e, Extended Data Figs. 1, 2).
The distributions of these main cell types, estimated from nuclei data, 
differ between atrial and ventricular tissues. Atrial tissues contain 30.1% 
cardiomyocytes, 24.3% FBs, 17.1% mural cells (pericytes and SMCs), 
12.2% ECs and 10.4% immune cells (myeloid and lymphoid). By contrast, 
ventricular regions (apex, interventricular septum, left and ventricle) 
contain 49.2% ventricular cardiomyocytes, 21.2% mural cells, 15.5% 
FBs, 7.8% ECs and 5.3% immune cells (Fig. 1d, Supplementary Table 2).
The ventricular proportions of ventricular cardiomyocytes and 
FBs are negatively correlated, whereas pericytes and SMC propor-
tions are positively correlated, indicating a functional organization 
(Supplementary Table 3). Cell distributions are generally similar 
in male and female hearts. However, the mean percentages of ven-
tricular cardiomyocytes from left and right ventricles are higher in 
female hearts (56 ± 9%; mean ± s.d.) and associated with a stronger 
negative correlation between ventricular cardiomyocytes and FBs 
(r = −0.8; slope = −0.9) compared to male hearts (47 ± 11%; P = 0.03; 
ventricular cardiomyocytes–FBs, r = −0.4; slope = −0.3). Differences 
in the proportions of cardiomyocytes is unexpected given the aver-
age smaller female heart mass, and if confirmed might explain higher 
cardiac stroke volumes in women5 and lower rates of cardiovascular 
disease.
Cardiomyocyte heterogeneity
Cardiomyocytes show high-level expression of genes that encode 
contractile force-generating sarcomere proteins (TTN, MYBPC3 and 
TNNT2) and calcium-mediated processes (RYR2, PLN and SLC8A1). Con-
sistent with bulk tissue RNA-sequencing (RNA-seq) data6, we observe 
markedly distinct transcriptional signatures in ventricular and atrial 
cardiomyocytes, reflecting developmental origins and differences in 
electrophysiological, contractile and secretory processes (Extended 
Data Fig. 3, Supplementary Table 4).
Ventricular cardiomyocytes are enriched in genes encoding sar-
comere proteins (MYH7 and MYL2), transcription factors (IRX3, IRX5, 
IRX6, MASP1 and HEY2), and PRDM16, mutated in left ventricular 
non-compaction cardiomyopathy7. Other abundant transcripts ena-
ble tissue integrity despite high ventricular strain: PCDH7 encodes a 
calcium-dependent strong adhesive molecule8; SMYD2 encodes a lysine 
methyltransferase that promotes sarcomere formation and stabiliza-
tion9. Atrial cardiomyocytes abundantly express prototypic genes and 
also ALDH1A2, an enzyme required for retinoic acid synthesis, ROR2, 
which participates in Wnt signalling during lineage differentiation10, 
and SYNPR, which functions in the mechanosensing of TRP channels 
by atrial volume receptors11.
We identify five ventricular cardiomyocyte (vCM1–vCM5) popula-
tions: vCM1 comprise 63.9% of left ventricular cardiomyocytes but 
only 36.7% of right ventricular cardiomyocytes (Fig. 2a, b, Extended 
Data Fig. 3a, c–e, Supplementary Tables 5, 6). vCM2 is more enriched in 
right ventricles (39.9%) than left ventricles (9.1%). However, differences 
between vCM1 and vCM2 are small, indicating shared gene programs 
between left (enriched in vCM1) and right (enriched in vCM2) ven-
tricles. vCM2 shows higher expression of PRELID2, a developmental 
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Fig. 1 | Cell composition of the adult human heart. a, Transmural samples 
were obtained from left and right atrium, left and right ventricles, apex and 
interventricular septum from 14 individuals. Single nuclei (n = 14) and single 
cells (n = 7) were processed using Chromium 10x 3′DEG chemistry.  
b, Infographic shows donors (women, top; men, bottom), age, and contribution 
to cells and nuclei datasets (orange circle). Data are available in Supplementary 
Table 1. c, Uniform manifold approximation and projection (UMAP) embedding 
of 487,106 cells and nuclei delineate 11 cardiac cell types and marker genes.  
d, Distribution of cell populations, identified from nuclei within atria (left and 
right) and ventricles (left, right, apex and interventricular septum) after 
subclustering analysis. Colour code as in c. Data are available in Supplementary 
Table 2. Adip, adipocytes; Lym, lymphoid; Meso, mesothelial cells; Myel, 
myeloid; NC, neuronal cells; PC, pericytes. e, Multiplexed smFISH of cell 
type-specific transcripts in right ventricles (RV; left): TTN (green, 
cardiomyocytes) and CDH5 (red, EC) right atrium (RA; middle): NPPA (green, 
aCM) and DCN (red, FB) and left atrium (LA; right): MYH11 (green, SMCs) and 
KCNJ8 (red, pericytes). Nuclei are counterstained with DAPI (dark blue). Scale 
bars, 20 μm. For details on statistics and reproducibility, see Methods.
468 | Nature | Vol 588 | 17 December 2020
Article
fluorescence in situ hybridization (smFISH) (Fig. 2c, Extended Data 
Fig. 3c). Among vCMs, vCM2 has the highest expression of the myosin 
gene MYH6 and CDH13, a cell surface T-cadherin receptor for cardio-
protective adiponectin and low density lipoproteins, both associated 
with several cardiometabolic traits13.
vCM3 and vCM4 are present across all ventricular regions. The 
vCM3 transcriptional profile resembles a prominent right atrium 
population (aCM3, discussed below) with retinoic-acid-responsive 
SMC gene enrichment (MYH9, NEXN and CNN1)14,15. vCM3 also express 
stress-response genes including ANKRD116, FHL117 (verified by smFISH) 
(Fig. 2d, Extended Data Fig. 3c), DUSP2718, and XIRP1 and XIRP2, inter-
acting with intercalated disc ion channel proteins implicated in cardio-
myopathy and arrhythmias19. The small population vCM4 is enriched 
for nuclear-encoded mitochondrial genes (NDUFB11, NDUFA4, COX7C 
and COX5B) and Gene Ontology terms indicative of a high energetic 
state (Extended Data Fig. 3f). vCM4 also demonstrates high levels of 
CRYAB, which encodes a cytoprotective and antioxidant heat shock 
protein20, of sarcomere protein genes and PLN, indicating that these 
ventricular cardiomyocytes are outfitted to perform higher workload 
than other ventricular cardiomyocytes.
vCM5 (approximately 1%) comprises cells with high levels of DLC1 and 
EBF221, regulating brown adipocyte differentiation and perhaps cardiac 
pacemaker activity, and transcripts identified in neuronal lineages 
(SOX5, EBF1 and KCNAB1). As EBF1-depleted mice have a profoundly 
hypoplastic ventricular conduction system22, vCM5 may participate 
in electrophysiology.
We identify five atrial cardiomyocyte populations (aCM1–aCM5) 
(Fig. 2e, f, Extended Data Fig. 3b–d, Supplementary Tables 6, 7). HAMP, 
a master regulator of iron homeostasis, is considerably enriched in 
more than 50% of right atrium cardiomyocytes versus 3% left atrium 
cardiomyocytes (verified by smFISH)23 (Fig. 2g, Extended Data Fig. 3c), 
indicating energetic differences6. HAMP has unknown roles in cardiac 
biology, but Hamp-null mice have deficits in the electron transport 
chain and lethal cardiomyopathy24.
aCM1 shows robust expression of prototypic atrial transcripts, indica-
tive of a basal atrial cardiomyocyte gene program, and lower levels 
of molecules with neuronal functions (ADGRL2, NFXL1 and ROBO2). 
aCM2 predominantly expresses HAMP within the right atrium and is 
enriched for SLIT3, the developmental ligand for cardiac ROBO recep-
tors25, ALDH1A226 and BRINP3, involved in retinoic acid signalling, and 
GRXCR2, supporting cilia involved in mechanosensing27.
aCM3 and vCM3 share similar transcriptional profiles including 
enrichment of the SMC gene CNN1 (verified by smFISH) (Fig. 2h, 
Extended Data Fig. 3c). The molecular signatures of aCM2, aCM3 and 
vCM3 indicate derivation from the second heart field28. aCM4 tran-
scripts denote high metabolic activity, similar to vCM4, and have the 
highest expression of NPPA. aCM5 expresses similar transcripts to 
vCM5.
Vascular, stromal and mesothelial cells
The vascular compartment includes 17 distinct populations of EC, 
SMC, pericyte, mesothelial cells with anatomical and arterio-venous 
specificities (Fig. 3a, b, Supplementary Tables 8, 9). Endothelial 
cells, identified by pan-EC markers PECAM1, CDH5 and VWF, com-
prise 10 populations (Extended Data Fig. 4a–c, g). Three capillary ECs 
(EC1-3_cap), which express RGCC and CA429, represent 57.4% of all ECs. 
Capillary-like EC4_immune ECs express transcripts related to antigen 
presentation and immune regulation (CX3CL1, CCL2, IL6 and ICAM1)30. 
Arterial EC5_art ECs are enriched for SEMA3G, EFNB2 and DLL4, whereas 
EC6_ven ECs express venous markers NR2F231 and ACKR132, which we 
confirmed by smFISH (Fig. 3c). Mainly atrial EC7_atria ECs express 
the angiogenesis regulator SMOC133 and NPR3, detected in mouse 
endocardium34, suggestive of endocardial cells. Lymphatic EC8_ln 
ECs, enriched for PROX1, TBX1 and PDPN, represent approximately 
1% of the captured ECs29.
Pericytes express ABCC9 and KCNJ8 and segregate into four clus-
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Fig. 2 | Cardiomyocytes. a, UMAP embedding of five ventricular 
cardiomyocyte (vCM) populations. b, Regional distributions of ventricular 
cardiomyocyte populations. Data are available in Supplementary Table 5.  
AX, apex; LV, left ventricle; SP, interventricular septum; RV, right ventricle.  
c, d, Multiplexed smFISH of PRELID2 (red) enriched in vCM2 (c) and of FHL1 
(red) enriched in vCM3 (d). e, UMAP embedding of five atrial cardiomyocytes 
(aCM) populations. f, Regional distributions of atrial cardiomyocyte 
populations. LA, left atrium; RA, right atrium. g, h, Multiplexed smFISH of 
HAMP (red) enriched in aCM2 (g) and of CNN1 (red) enriched in aCM3 (h). In c, d, 
g and h, nuclei are counterstained with DAPI (dark blue). Scale bars, 10 μm. For 
details on statistics and reproducibility, see Methods.
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in atria. PC1_vent cells express adhesion molecules (NCAM2 and 
CD38), and CSPG4, which is involved in microvascular morphogen-
esis and EC cross-talk35 (Extended Data Fig. 4d–f). PC3_str co-express 
pericyte markers and very low levels of pan-EC transcripts. RNA 
velocity analyses suggest a directionality that indicates PC3_str 
cells as a transitional state between pericytes and ECs (Extended 
Data Fig.  4h, i). These observations may relate to bidirectional 
pericyte or endothelial cell (trans)differentiation, which remains 
controversial36.
Vascular SMCs that express MYH11 split into two populations. 
SMC1_basic cells express transcripts that indicate immaturity, includ-
ing the stem-cell marker LGR637 and proliferation-associated RGS538. 
SMC2_art cells express considerably higher levels of CNN1, ACTA2 and 
TAGLN, indicating arterial origin, whereas SMC1_basic cells may be 
venous-derived39 (Extended Data Fig. 4d–f).
Cell–cell interaction analyses indicate connections between ECs and 
mural cells in different vascular segments (Fig. 3b–d, Extended Data 
Fig. 4j, k, Supplementary Table 10), including Notch receptor–ligand 
interactions40 (NOTCH1 or NOTCH4 with JAG1, and NOTCH2 or NOTCH3 
with JAG1, JAG2 or DLL4) between EC5_art and SMC2_art cells. Explora-
tory spatial transcriptomics (Extended Data Fig. 5) shows co-occurrence 
of EC5_art and SMC2_art markers and JAG1 and NOTCH2, thereby sup-
porting this interaction between ECs and SMCs. A venous-specific 
DLL1–NOTCH3 interaction is predicted for EC6_ven and SMC1_basic 
cells. Notably, many of the venous and arterial EC predicted interac-
tions are shared with capillary ECs, which suggests gradual changes 
along the arterio-venous axis39.
We define a distinct small population as mesothelial cells that enrich 
for MSLN, WT1 and BNC141 but lack EC, FB or mural genes. smFISH 
confirms this annotation with localization of BNC1+/CDH5− cells to 
the epicardium (Extended Data Fig. 4l–n).
Cardiac fibroblasts
Cells of the FB compartment show enriched expression of DCN, GSN and 
PDGFRA within seven populations (Fig. 3g) with regional enrichment 
in ventricles (FB1) and atria (FB2). This is consistent with distinctive 
functional properties, including stronger profibrotic responses, by 
atrial FBs42. FB1 and FB2 cells express canonical genes and define a 
basal, chamber-specific FB expression program (Extended Data Fig. 6a, 
Supplementary Table 11).
FB4 and FB5 cells are less abundant in the right atrium than other 
regions, whereas FB3 are less abundant in the left ventricle (Extended 
Data Fig. 6c). FB4 cells express genes responsive to TGFβ signalling (for 
example, POSTN and TNC) (Fig. 3e). FB5 cells have higher expression 
of genes involved in the production, remodelling and degradation of 
extracellular matrix (ECM). By contrast, FB3 cells have lower expression 
of ECM-related genes but higher expression of cytokine receptors such 
as OSMR and ILST643 (Fig. 3f, Extended Data Fig. 6b, Supplementary 
Table 12). These distinctive fibroblast gene programs probably govern 
stress-responsive cardiac remodelling and contribute to homeostasis.
Separate clustering of atrial and ventricular FBs recapitulated the 
populations described above, including an OSM-signalling popula-
tion in each chamber (aFB4 and vFB3). In addition, we identify distinct 
chamber-specific ECM-producing FBs that differ in the expression of 
collagen isoforms and other ECM-related (aFB2 versus vFB2) (Extended 
Data Fig. 6g–m, Supplementary Table 13) or connective tissue-related 


































































































































































Fig. 3 | Vascular, stromal and mesothelial cells. a, UMAP embedding of  
17 vascular and mesothelial populations. EC1/2/3_cap, capillary ECs; EC4_
immune, immune-related ECs; EC5_art, arterial ECs; EC6_ven, venous ECs; EC7_
atrial, atria-enriched ECs; EC8_ln, lymphatic ECs; EC9_FB-like, ECs with FB 
features; EC10_CM-like, ECs with cardiomyocyte features; PC1_vent, 
ventricle-enriched pericytes; PC2_atrial, atria-enriched pericytes; PC3_str, 
stromal pericytes; PC4_CM-like, pericytes with cardiomyocyte features; SMC1_
basic, basic SMCs; SMC2_art, arterial SMCs. b, Schematic of the vascular cells 
and their placement in the vasculature. c, Multiplexed smFISH of MYH11 
(yellow) in SMC (thick in artery and very thin in small vein), CDH5 (red) in the 
endothelium, and SEMA3G (cyan) and ACKR1 (green) in EC5_art and EC6_ven, 
respectively in apex. Nuclei are counterstained with DAPI (dark blue). Scale bar, 
20 μm. d, Predicted cell–cell interactions in arteries and veins. Data are 
available in Supplementary Table 10. e, f, Multiplexed smFISH of pan-FB DCN 
(cyan) and FAP (red) in FB4 in interventricular septum (SP) (e) and DCN (cyan) 
and LINC001133 (red) in FB5 in the apex (AX) (f). Nuclei are counterstained with 
DAPI (dark blue). Scale bars, 5 μm. g, UMAP embedding showing six FB 
populations and their respective marker genes. h, Multiplexed smFISH of 
C1QA+ macrophages (MP) and PTX3+ FB3, suggesting cross-talk between both 
cell types. Scale bar, 5 μm. For details on statistics and reproducibility, 
see Methods.
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Immune cells and cardiac homeostasis
Analysis of cardiac immune cells reveals 21 cell states (Fig. 4a, Extended 
Data Fig. 7). Myeloid cells comprise 13 populations, including several 
subtypes of macrophages, monocytes and dendritic cells, whereas the 
lymphoid compartment comprises 8 populations (Supplementary 
Tables 14, 15).
Macrophages include three LYVE1+ macrophage populations: LYVE1+ 
MP1–2 enrich for clathrin and cathepsin genes, and LYVE1+ MP3 for 
HLA-DOA, HLA-DQA1/2 and HLA-DQB1. LYVE1+ macrophages appear 
related to recently described tissue-resident macrophages associ-
ated with cardiovascular remodelling44, although negative for TIMD445 
(Extended Data Fig. 8a, b). Monocyte-derived macrophages express 
LYVE1 and FOLR2, monocyte-like markers CEBPB and S100A8, and che-
moattractant cytokine genes CCL13 and CCL18. Antigen-presenting 
macrophages are FOLR2−, LYVE1− and MERTK−, and enrich for 
HLA-DRA, HLA-DMA, HLA-DMB, HLA-DPA1 and TREM2 (described in 
lipid-associated macrophages)46. Although monocytes are abundant in 
our data and others47, these are likely to be circulating, as supported by 
computational integration of our data with published peripheral blood 
mononuclear cell (PBMC) single-cell RNA-seq data (Supplementary 
Table 16). Two populations of DOCK4+ macrophages differentiated 
by higher expression of IL4R, STAT3 and ITGAM in DOCK4+ MP1 versus 
DOCK4+ MP2, do not express C1QA or FOLR2 (Extended Data Fig. 8c).
Predicted cell–cell interactions identify receptor–ligand cir-
cuits among immune cells, cardiomyocytes, and FBs. LYVE1+, 
monocyte-derived and antigen-producing macrophages are predicted 
to interact with FB4 via CD74–MIF (Fig. 4b, Extended Data Fig. 8d, e, 
Supplementary Table 17). Inhibition of this interaction leads to fibrosis48 
and tissue damage49. FB4 also enrich for FN1, COL4A1 and TNC, facilitat-
ing cellular proliferation in the fetal heart50 and predicted to interact 
with different integrins in atrial and ventricular cardiomyocytes. In 
skeletal muscle (SKM), predicted cell–cell interactions between PRG4+ 
FBs (analogous to FB4) and cardiomyocytes involve COL1A2, COL6A2 
and α10β1 integrins, whereas SKM FBs and monocytes appear to inter-
act via the ICAM1–AREG and CXCR4–CXCL12 chemokine pairs (Fig. 4b, 
Supplementary Table 18), indicating tissue-specific homeostatic tran-
scriptional circuits.
Using a logistic regression model, we find that lymphoid cells 
are more similar across heart, SKM and kidney, whereas there is 
less concordance for myeloid cells (Extended Data Fig. 8f, Supple-
mentary Tables 16, 19), probably due to tissue-specific adaptability 
of myeloid cells51. Notably, populations corresponding to cardiac 
monocyte-derived macrophages, LYVE1+ MP1, DOCK4+ MP1–2 and 
antigen-presenting macrophages are absent from the SKM and kid-
ney. Cardiac LYVE1+ MP2–3, pro-inflammatory monocytes, classical 
monocytes and mast cells are more similar to their SKM counter-
parts, indicating greater similarity of striated muscle and cardiac 
myeloid populations versus kidney. The transcriptional signature of 
cardiac LYVE1+ MP2-3 is specific without overlap in SKM and kidney 
(Fig. 4c).
Conduction system and neuronal cells
Among 3,961 cells expressing prototypic electrophysiologic transcripts 
(NRXN1, NRXN3 and KCNMB4), we identify six neuronal cell subclusters 
(Extended Data Fig. 9a–c). NC1 constitutes 75–80% of neuronal cells and 
exhibits a basal gene program including LGI4, required for glia devel-
opment and axon myelination52. NC2 and NC4 show strong expression 
of the central nervous system marker, PRKG153, and co-express typical 
fibroblast and cardiomyocyte genes, respectively. NC3 has overlapping 
gene expression signatures with ECs. NC5 expresses LGR5, a Wnt signal-
ling, G-protein-coupled receptor and stem-cell marker that promotes 
cardiomyocyte differentiation in the outflow tract54, an arrhythmogenic 
area55. This cluster also expresses the neurodegenerative disease gene 
PPP2R2B56 (verified by smFISH) (Extended Data Fig. 9d, Supplementary 
Table 20); LSAMP, which guides the development of specific patterns 
of neuronal connections57; and the lipoprotein transport enzyme LPL 
that remyelinates damaged neurons58. NC6 mimics Schwann cells, 
expressing MBP, PRX and MPZ, which encode myelin constituents59.
Adipocytes
Cardiac adipocytes uniformly express GPAM, FASN and ADIPOQ and at 
lower levels, LEP60 (Extended Data Fig. 9e–h). ADIP1 expresses genes for 
PPAR pathways, metabolism of lipids and lipoproteins, and lipolysis. 
ADIP2 expresses ECM genes such as LAMA2, IGFBP7 and FBN1, which 
encodes both the glycoprotein fibrillin1 and asprosin, a white adi-
pose tissue secreted hormone involved in glucose homeostasis (Sup-










































































Fig. 4 | Cardiac immune populations and cell–cell interactions. a, Manifold 
of 40,868 myeloid and lymphoid cardiac cells. NP, neutrophils; NK, natural 
killer; NKT, natural killer T cells; CD4+T_tem, effector-memory CD4+ T cells; 
CD4+T_cytox, CD4+ cytotoxic T cells; CD8+T_tem, CD8+ effector-memory 
T cells; CD8+T_cytox, CD8+ cytotoxic T cells; DC, dendritic cells; CD14+Mo, 
CD14+ monocytes; CD16+Mo, CD16+ monocytes; Mo_pi, pro-inflammatory 
monocytes; IL17RA+Mo, IL17RA+ monocytes; MP_AgP, HLA class II 
antigen-presenting macrophages; MP_mod, monocyte-derived macrophages; 
LYVE1+MP1–3, M2-like, LYVE1+ macrophages sets 1–3; DOCK4+MΦ1–2, DOCK4+ 
macrophage sets 1–2; B_cells, B cells; plasma, plasma B cells. b, BioRender 
infographic summarizes predicted cell–cell interaction circuits between atrial 
and ventricular cardiomyocytes, FB4 and immune cells involved in tissue repair 
in the heart and SKM. Data are available in Supplementary Table 17. c, Gene 
expression signature for cardiac-specific LYVE1+ macrophages compared 
against predicted matched populations in skeletal muscle and kidney.
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ADIP2 cells may represent fibrogenic adipocytes and/or precursors61,62. 
ADIP3 transcripts encode inflammatory and cytokine responsive 
molecules.
COVID-19 and GWAS disease relevance
Transcripts encoding the severe acute respiratory syndrome coronavi-
rus 2 (SARS-CoV-2) receptor ACE263 are highest in pericytes, followed by 
FBs and lowest in cardiomyocytes, where expression is twofold higher 
in ventricular than atrial cardiomyocytes. Among proteases priming 
viral entry63, TMPRSS2 transcripts are absent in pericytes, FBs and car-
diomyocytes, whereas CTSB and CTSL are lowly expressed with higher 
levels in cardiomyocytes. ACE2 expression in pericytes and fibroblasts 
is depicted by smFISH (Extended Data Fig. 10a–e).
We define cells enriched for genes from 12 cardiovascular 
genome-wide association studies (GWAS) and involved in SARS-CoV-2 
infection using MAGMA64 (Extended Data Fig. 10f). Atrial fibrillation 
GWAS signals are associated with transcriptional profiles in vCM3, 
owing to higher mean expression of CAV1, CAV2 and PRRX1. PR interval 
GWAS signals are associated with vCM3 and aCM5, with high expres-
sion of SCN5A, CAV1, ARHGAP24, MEIS1, TBX5 and TTN. GWAS signals 
for QRS duration are associated with specific gene expression in NC2 
(PRKCA, CEP85L, SLC35F1, SIPA1L1, KLF12 and FADS2). Coronary artery 
disease and hypertension GWAS signals are associated with transcripts 
from many cell lineages, particularly SMCs, FBs, and ECs, reflecting the 
relevance of vascular cells in both disorders.
Discussion
Our analyses of approximately half a million single cells and nuclei 
from six distinct cardiac regions from fourteen donors considerably 
expand an emerging reference adult heart cell atlas. By combining 
single-cell and single-nuclear RNA-seq data with machine learning 
and in situ imaging techniques, we provide detailed insights across 
the repertoire of cardiac cells, including cardiomyocytes (excluded by 
single-cell RNA-seq) and ECs (underrepresented in cardiac snRNA-seq). 
We quantify the cellular composition highlighting chamber-specific 
features and differences between male and female donors. Within each 
cell compartment, we identify and validate prototypic lineage-specific 
genes, and genes with previously unknown cardiac expression. Our 
results begin to unravel the molecular underpinnings of cardiac physi-
ology and the cellular response to stress and disease.
Cardiomyocytes are the most prevalent cardiac cells and comprise 
higher percentages in ventricles than atria, and in female versus male 
ventricular tissues. Transcriptional differences between atrial and ven-
tricular cardiomyocyte populations indicate different developmental 
origins, distinctive haemodynamic forces and specialized functions 
in cardiac chambers. Cellular diversity of FBs reveals ECM-producing 
and ECM-organizing activities that with other cells support cardiomyo-
cytes across varying biophysical stimuli. The vascular compartment 
contains several ECs and pericyte populations and two SMC subtypes 
with distinct anatomical and arterio-vascular characteristics. Arterial 
and venous ECs are predicted to interact with mural cells via Notch 
signalling pathways involved in regulating vascular homeostasis and 
development. Immune cells interact with FBs and cardiomyocytes. In 
addition to confirming previous findings65,66, we show macrophage 
complexity and infer paracrine circuits for cardiac homeostasis. 
Cross-tissue analyses delineate cardiac populations distinct from 
skeletal muscle and kidney.
We illustrate the relevance of cardiac cell atlas by defining cell lin-
eages enriched in cardiovascular GWAS and molecules involved in 
SARS-CoV-2 infection. High expression of the viral receptor ACE2 in 
pericytes and its correlation with AGTR1 is consistent with the role 
of renin–angiotensin–aldosterone system signalling in cardiac 
haemodynamics67.
We recognize limitations associated with cell capture by different 
data sources and unintended bias from surgical sampling. However, we 
expect our results will inform studies of other cardiac regions (valves, 
papillary muscle and conduction system), propel studies with large 
cohorts to determine the roles of age, gender and ancestry on normal 
cardiac physiology and provide crucial insights to enable mechanistic 
understanding of heart disease.
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Methods
Data reporting
No statistical methods were used to predetermine sample size. The 
experiments were not randomized, and investigators were not blinded 
to allocation during experiments and outcome assessment.
Research ethics for donor tissues
Heart tissues (donors D1–D7 and D11) were processed at Wellcome 
Sanger Institute (Hinxton, UK) and obtained from deceased trans-
plant organ donors after Research Ethics Committee approval (ref 
15/EE/0152, East of England Cambridge South Research Ethics Com-
mittee) and informed consent from the donor families. Heart tissues 
(donors H2–H7) were processed at Harvard Medical School (Boston, 
Massachusetts, USA) and obtained from deceased organ donors after 
Human Research Ethics Board approval Pro00011739 (University of 
Alberta, Edmonton, Canada). Informed consent from donor families 
was acquired via the institutional Human Organ Procurement and 
Exchange Program (HOPE). Cardiovascular history was unremarkable 
for all donors (Supplementary Table 1).
Tissue acquisition and processing
Tissues were acquired from UK and North American donors (D1–7 
and 11, H2–7) after circulatory death (DCD) (D2, D4–D7 and D11) and 
after brain death (DBD) (D1, D3, H2–H7). For UK DCD donors, after a 
five-minute stand-off and for DBD, the chest is opened, the aorta is 
cross-clamped and cardiac samples are acquired. For North American 
DBD donors, the aorta is cross-clamped, cold cardioplegia (Celsior) is 
administered under pressure via the aorta to arrest beating, the heart 
is excised, rinsed in cold saline and samples acquired. All donor sam-
ples were full-thickness myocardial biopsies from the left and right 
atrium, left and right ventricles, interventricular septum and apex, with 
intentional exclusion of large epicardial fat deposits. Samples used for 
single nuclei isolation were flash-frozen and stored at −80 °C. Single-cell 
isolation and CD45+ enrichment was carried out on freshly collected 
samples. Residual tissue after nuclei and cell isolation procedures was 
formalin-fixed or frozen in OCT for additional studies.
All tissues were stored and transported on ice at all times until freezing 
or tissue dissociation to minimise any transcriptional degradation. Previ-
ous studies on the post-mortem tissue stability of the GTEx consortium 
on bulk tissues68 and in single cells69 suggest only minor changes in tis-
sues within the first 24 h post mortem when stored in cold conditions.
Single nuclei isolation
Single nuclei were obtained from flash-frozen tissues using mechanical 
homogenization as previously described70. Tissues were homogenized 
using a 7 ml glass Dounce tissue grinder set (Merck) with 8–10 strokes of 
a loose pestle (A) and 8–10 strokes of a tight pestle (B) in homogeniza-
tion buffer (250 mM sucrose, 25 mM KCl, 5 mM MgCl2, 10 mM Tris-HCl, 
1 mM dithiothreitol (DTT), 1× protease inhibitor, 0.4 U μl−1 RNaseIn, 
0.2 U μl−1 SUPERaseIn, 0.1% Triton X-100 in nuclease-free water). 
Homogenate was filtered through a 40-μm cell strainer (Corning). 
After centrifugation (500g, 5 min, 4 °C) the supernatant was removed 
and the pellet was resuspended in storage buffer (1× PBS, 4% bovine 
serum albumin (BSA), 0.2 U μl−1 Protector RNaseIn). Nuclei were 
stained with NucBlue Live ReadyProbes Reagents (ThermoFisher) and 
Hoechst-positive single nuclei were purified by fluorescent activated 
cell sorting (FACS) using influx, XDP or FACSAria (BD Biosciences) (Sup-
plementary Fig. 1). Nuclei purification and integrity was verified under 
a microscope, and nuclei were further processed using the Chromium 
Controller (10X Genomics) according to the manufacturer’s protocol.
Single-cell preparation
Heart tissues (0.2–0.9 g) were transferred from cardioplegic solution 
into gentleMACS C-tubes (Miltenyi Biotec) containing enzymatic 
digestion base solution (100 μg ml−1 liberase TH Research grade and 
50 μg ml−1 DNase I, HBSS 10 mM HEPES and 30 mM taurine)71. Tis-
sues were minced using scissors (FST) and automatically digested 
using gentleMACS Octo Dissociator (Miltenyi Biotec) with heaters. 
Cardiomyocyte-depleted single-cell suspension were washed with 
base solution containing 20% fetal bovine serum (FBS) (Gibco), filtered 
through 70-μm nylon strainer (BD Falcon), collected by centrifugation 
(330g, 10 min, 4 °C) and resuspended in base solution containing 0.2% 
FBS (Gibco). Cells were manually counted three times by Trypan blue 
exclusion after each centrifugation and resuspended at a concentra-
tion of at least 2 × 106 ml−1. Single cells were processed using Chromium 
Controller (10X Genomics) according to the manufacturer’s protocol.
CD45+ cell enrichment
Cell suspension was prepared as described above and subsequently 
labelled using anti-human CD45 monoclonal antibody-conjugated 
microbeads according to the manufacturer’s protocol (Miltenyi Bio-
tec). In brief, up to 107 cells were incubated for 15 min at 4 °C in 80 μl of 
PBS, BSA, EDTA buffer (1× PBS pH 7.2, 0.5% BSA, 2 mM EDTA) contain-
ing 20 μl CD45 microbeads. Cell suspension was washed in PBS, BSA, 
EDTA buffer once and collected by centrifugation (330g, 10 min, 4 °C). 
Resuspended cells were applied to MACS LS columns (Miltenyi Biotec). 
CD45-depleted cell fraction was discarded after three washes with PBS, 
BSA and EDTA buffer and the CD45+ cell fraction was collected in PBS, 
BSA and EDTA buffer by removal of the columns from the magnetic 
field. CD45+ cells were counted and resuspended in PBS, BSA and EDTA 
buffer to a concentration of at least 2 × 106 per ml before further pro-
cessing using a Chromium Controller (10X Genomics) according to 
the manufacturer’s protocol.
Chromium 10X library preparation
Single cells and nuclei were manually counted by Trypan blue exclu-
sion or automatically using a Countess II (Life Technologies) using at 
least two separate counts. Cell or nuclei suspension was adjusted to 
400–1,000 cells per microlitre and loaded on the Chromium Controller 
(10X Genomics) with a targeted cell or nuclei recovery of 4,000–10,000 
per reaction. 3′ gene expression libraries were prepared according to 
the manufacturer’s instructions of the v2 or v3 Chromium Single Cell 
Reagent Kits (10X Genomics). Quality control of cDNA and final libraries 
was done using Bioanalyzer High Sensitivity DNA Analysis (Agilent) or 
4200 TapeStation System (Agilent). Libraries were sequenced using 
HiSeq 4000 (Illumina) at Wellcome Sanger Institute, and NextSeq 500 
(Illumina) at Harvard Medical School with a minimum depth of 20,000–
30,000 read pairs per cell or nucleus (Supplementary Table 22).
Spatial validation using smFISH with RNAscope probes
During preparation of formalin-fixed paraffin-embedded (FFPE) sam-
ples fresh tissue was fixed in neutral-buffered 10% formalin for 18–36 h 
and subsequently embedded in paraffin blocks. Fixed-frozen tissue 
samples were fixed in 4% paraformaldehyde (ThermoFisher). Sections 
were cut at 5-μm thickness using a microtome and placed onto Super-
Frost Plus slides (VWR). FFPE tissue slides were automatically stained 
using BOND RX (Leica) and the RNAscope Multiplex Fluorescent Rea-
gent Kit v2 Assay (ACDBio) according to the manufacturer’s protocol. 
Fixed-frozen tissue slides were processed according to the protocol 
of RNAscope Multiplex Fluorescent Assay v1 (ACDBio). RNAscope 
ready- or custom-made target probes were run in parallel to multi-
plex positive and negative controls (Extended Data Fig. 12b, Supple-
mentary Table 23). All nuclei were DAPI-stained. All FFPE tissue slides 
were imaged using an Opera Phenix High-Content confocal Screening 
System (Perkin Elmer) with a 1-μm z-step size and 20× water-immersion 
objective (NA 0.16, 0.299 μm per pixel). Channels: DAPI (excitation 
375 nm, emission 435–480 nm), Atto 425 (excitation 425 nm, emission 
463–501 nm), opal 520 (excitation 488 nm, emission 500–550 nm), opal 
570 (excitation 561 nm, emission 570–630 nm), opal 650 (excitation 
Article
640 nm, emission 650–760 nm). Fixed-frozen tissue slides were imaged 
using a LSM710 confocal microscope (Zeiss) and 40× oil-immersion 
objective (1.3 oil, DIC III). Channels: DAPI (excitation 375 nm, emission 
435–480 nm), Alexa Fluor 488 (excitation 492 nm, emission 517 nm), 
Atto 550 (excitation 560 nm, emission 575 nm) and Atto 647 (excitation 
649 nm, emission 662 nm). Visualization and background removal 
(rolling ball radius) were done using Fiji/ImageJ72. Pseudocolours were 
used for better visualization.
Haematoxylin and eosin staining
Tissue samples were fresh-frozen in isopentane (ThermoFisher) at 
−80 °C and embedded in OCT (VWR). Sections were cut at a thickness 
of 10 μm using a microtome, placed onto SuperFrostPlus slides (VWR) 
and further processed according to a standard haematoxylin and eosin 
staining protocol (Extended Data Fig. 12a).
Acquisition of skeletal muscle tissue
Intercostal muscle samples were obtained from between the second 
and third rib on the left side. This is typically from the deepest layer of 
muscle (furthest away from the skin). Samples were collected directly 
into the cold preservation solution.
Nuclei isolation for skeletal muscle
Muscle tissue was washed in 1× PBS, cleaned of any visible fat depositions 
and minced to obtain fragments of approximately 1 mm3. Per sample, 
approximately 0.3 g of minced tissues was homogenized in 3 ml of buffer 
A (250 mM sucrose, 10 mg ml−1 BSA, 5 mM MgCl2, 0.12 U μl
−1 RNaseIn, 
0.06 U μl−1 SUPERasIn, 1× protease inhibitor) using Dounce tissue grinder 
set (Merck) with 50 strokes of the loose pestle (A). The homogenate was 
filtered through a 100-μm cell strainer (Corning) and the strainer was 
washed with 1 ml and then 750 μl of buffer A. After the addition of Triton 
X-100 (final concentration 0.5%), the mixture was further homogenized 
with 50 strokes of the tight pestle (B). After filtering through a 40-μm 
strainer, nuclei were centrifuged (3,000g, 5 min, 4 °C), resuspended in 
1 ml of buffer B (320 mM sucrose, 10 mg ml−1 BSA, 3 mM CaCl2, 2 mM mag-
nesium acetate, 0.1 mM EDTA, 10 mM Tris-HCl, 1 mM DTT, 1× protease 
inhibitor, 0.12 U μl−1 RNaseIn, 0.06 U μl−1 SUPERasin) and purified using 
a 27% Percoll gradient solution. The Percoll mixture was centrifuged at 
20,000g (15 min, 4 °C) and the pellet was resuspended in 200 μl of buffer 
B, followed by centrifugation (20,000g, 3 min, 4 °C). After Trypan Blue 
staining, the intact nuclei were counted using a haemocytometer. Nuclei 
were profiled using a Chromium Controller (10X Genomics) according 
to the manufacturer’s protocol.
Single-cell isolation for skeletal muscle
Muscle tissue was washed in 1× PBS, cleaned of any visible fat deposi-
tions and finely minced. Then, 2 g of the minced tissue was transferred 
to digestion buffer 1 (750 U ml−1 collagenase type 2 in 1× PBS) and incu-
bated at 37 °C in a water bath for 90 min. The partially digested tis-
sue was collected by centrifugation (650g, 5 min, 4 °C) and the pellet 
was resuspended in digestion buffer 2 (100 U ml−1 collagenase type 2, 
2 U ml−1 dispase in PBS). After 30 min incubation at 37 °C in a water bath, 
the digestion was stopped by the addition of 2% FBS. Cells were filtered 
through a 100-μm and a 40-μm nylon strainer (BD Falcon), collected 
by centrifugation (650g, 4 °C, 3 min) and washed with 1× PBS, 2% FBS. 
Subsequently, a 20% Percoll gradient (15,000g, 4 °C, 20 min) was used for 
cell purification. The layer containing cells was collected, washed in PBS 
containing 2% FBS, and viable cells were counted by Trypan Blue exclu-
sion using a haemocytometer. Nuclei were profiled using a Chromium 
Controller (10X Genomics) according to the manufacturer’s protocol.
The methods key resources table is in Supplementary Table 24.
Transcriptome mapping
After sequencing, samples were demultiplexed and stored as CRAM 
files. Each sample was mapped to the human reference genome 
(GRCh38 v.3.0.0) provided by 10X Genomics, and using the CellRanger 
suite (v.3.0.1) with default parameters. Single-cell samples were mapped 
against the reference as it was provided. Single-nuclei samples, the 




After mapping, samples from each data source (single nuclei, single 
cell and CD45+ cell) were grouped into individual AnnData objects by 
concatenating the raw_feature_bc_matrix_h5.h5 and adding the appro-
priate metadata information. For each data source object, the mean 
of unique molecular identifiers (UMIs) (n_counts) was calculated and 
used as a threshold for empty droplets.
Doublet detection
After removal of empty droplets, we applied scrublet73 to assign a dou-
blet score (scrublet_score) to each cell. These cells were clustered and 
visualized using the UMAP method74. In addition, each cell was pro-
cessed for doublet detection using a percolation method to allow for 
improved detection of doublets75.
Cell quality control and filtering
Each data source was processed and annotated separately to account 
for source-specific quality differences. These metrics are included 
as covariates for further processing. Total cells and CD45+ cells were 
filtered for counts (500 < n_counts <15,000), genes (200 < n_genes), 
mitochondrial genes (percent_mito <20%), ribosomal genes (percent_
ribo <20%) and scrublet score (scrublet_score <0.3). Single nuclei were 
filtered for counts (500 < n_counts <15,000), genes (300 < n_genes 
<6,000), mitochondrial genes (percent_mito <5%), ribosomal genes 
(percent_ribo <5%) and scrublet score (scrublet_score <0.3). The same 
filtering thresholds were applied to the skeletal muscle dataset.
Scanpy toolkit 1.576 in Python v.3.7 was used to perform downstream 
analyses, including normalization (normalize_per_cell: counts_per_cell_
after = 10,000), log transformation (log1p), variable gene detection 
(highly_variable_genes), regressing out unwanted sources of variation 
(regress_out: n_counts and percent_mito), data feature scaling (scale: 
max_value = 10) and PCA (pca: using highly variable genes) as previ-
ously described77.
Batch alignment using deep variational autoencoder
We built a global manifold by aligning all the data sources and donors 
in our data. This was done in a three-step procedure: (1) Each source 
was analysed and annotated separately, aligning only for donors using 
a pericyte-space linear regression step before batch alignment with 
bbknn78. Differentially expressed genes (DEGs) were calculated using 
a Wilcoxon rank sum test with Bonferroni–Hochberg adjustment as 
implemented in the Scanpy framework. (2) To annotate each cluster, 
we used an integrative approach by searching the top significant DEGs 
(P < 1 × 10−5) with a logFC >1 against the ToppFun79 and EnrichR80 data-
bases. Significant hits on pathways, transcriptional regulation and 
biological processes were prioritized to annotate a given cluster. Each 
cellular compartment was labelled under the adata.obs[‘cell_type’] slot 
after grouping source-specific cell states. (3) All sources were combined 
into a single AnnData object under the label adata.obs[‘cell_sources’]. 
Batches were aligned using the batch_correction function from the 
scGen variational autoencoder81. First we align for adata.obs[‘cell_
sources’], using adata.obs[‘cell_type’] as an anchor. Next, we aligned 
for adata.obs[‘donor’], using adata.obs[‘cell_type’] as an anchor. Each 
batch alignment round was run for 50 epochs.
Manifolds for the adipocytes, vascular and immune cardiac pop-
ulations, as well as the skeletal muscle analysis, were created using 
this method and the clustering accuracy was evaluated with SCCAF82 
(Extended Data Fig. 12d).
DEGs
To help with the annotation of the subpopulations of each cell com-
partment, we calculated the DEGs using the Wilcoxon rank sum test 
as implemented in the scanpy workflow and recommended by recent 
benchmarking studies83. A gene was considered to be differentially 
expressed if it has a log2-transformed fold change > 1 and a P < 1 × 10
−5, 
unless stated otherwise in the analysis section.
Cell–cell interactions
Expression matrices of the populations under study were exported 
from the AnnData, together with a metadata table that contained 
the cell-barcodes as indices. We then ran CellPhoneDB as follows: 
cellphonedb method statistical_analysis meta.tsv counts.tsv–
counts-data = gene_name–threads = 60. CellPhoneDB raw predictions 
were filtered by removing those interactions with a P > 1.0 × 10−5. Sig-
nificant pairs were then submitted for gene set enrichment analysis 
into ReactomeDB, enrichR and ToppFun for functional classification. 
The vascular cells were randomly sub-sampled to 39,000 cells before 
the analysis, and the cardiac repair group (atrial and ventricular car-
diomyocytes, FBs, and immune cells) was randomly sub-sampled to 
69,295 cells before the analysis.
Visualization of gene expression on 10X Genomics Visium data
We processed the publicly available left ventricular myocardium 
Visium data from 10X Genomics (https://support.10xgenomics.com/
spatial-gene-expression/datasets/1.0.0/V1_Human_Heart) using 
the Scanpy v.1.5 workflow adapted for the analysis of 10X Genomics 
Visium data (https://scanpy-tutorials.readthedocs.io/en/latest/spatial/ 
basic-analysis.html). In brief, spots were removed with less than 
500 UMIs or more than 20,000 UMIs, and less than 200 genes. Data 
were log-transformed and normalized before plotting.
Estimation of RNA velocity
To calculate the RNA velocity of the single cells and CD45+ enriched 
single cells, we used the CellRanger output BAM file and the GENCODE 
v33 GTF (ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/
release_33/gencode.v33.chr_patch_hapl_scaff.annotation.gtf.gz) file 
together with the velocyto84 CLI v.0.17.17 to generate a loom file con-
taining the quantification of spliced and unspliced RNA. Next, we built a 
manifold, cluster the cells and visualize the RNA velocities using scVelo85.
Subpopulation analyses of atrial and ventricular 
cardiomyocytes, FBs and neuronal cells
All barcodes labelled in the global object as cardiomyocytes, fibroblasts 
and neural cells were selected for further subpopulation analyses. 
Additional cell population-specific filtering criteria were applied to 
nuclei as follows: cardiomyocyte counts (n_counts <12,500), genes 
(n_genes <4,000), mitochondrial genes (percent_mito <1%), ribosomal 
genes (percent_ribo <1%) and scrublet score (scrublet_score <0.25); 
FB mitochondrial genes (percent_mito <1%), ribosomal genes (per-
cent_ribo <1%); neuronal cell genes (n_genes <4000), mitochondrial 
genes (percent_mito <1%), ribosomal genes (percent_ribo <1%). Total 
and CD45+ cells were excluded in the atrial and ventricular cardiomyo-
cytes datasets and did not contribute to subpopulation analysis. No 
further filtering of FBs or neuronal cell total and CD45+ cells was applied. 
Cardiomyocytes and FBs were then further split into two groupings 
based on the region of origin: (1) left and right atrium, and (2) left and 
right ventricles, apex and interventricular septum.
Donor effects were aligned as described in step (1) above. For FB and 
neuronal cells, sources were aligned as described in step (3) above. 
Leiden clustering and UMAP visualization were performed for iden-
tifying subpopulations and visualization86. Differentially expressed 
genes were calculated using the Wilcoxon rank sum test. Genes were 
ranked by score.
Cross-tissue comparison of cardiac immune populations with 
skeletal muscle, kidney and blood immune populations
We collected single-cell transcriptome data for adult kidneys from 
ref. 99 (https://www.kidneycellatlas.org/), and subset all immune cells 
reported in their study. For the SKM we selected the annotated immune 
cells from the merged manifold. For the human blood, we used the pub-
licly available 10,000 single PBMC cells dataset provided by 10X Genom-
ics (https://support.10xgenomics.com/single-cell-gene-expression/
datasets/3.0.0/pbmc_10k_v3). As previously described87, we trained 
a logistic regression model on the cardiac immune cells using 80% of 
the expression data and tested its accuracy on the remaining 20% to 
produce a model with an accuracy of 0.6862 (Extended Data Fig. 8f, Sup-
plementary Table 16). We then applied this model to predict analogue 
cardiac immune populations in the adult kidney, SKM and PBMCs. 
Predictions with a probability less than 0.8 were excluded from down-
stream comparative analyses.
Gene Ontology enrichment analysis
For the ventricular cardiomyocyte population, we used the R package 
gProfileR (https://cran.r-project.org/web/packages/gProfileR/index.
html) with the score-ranked gene list of vCM4 as input and the set of 
genes expressed in ventricular cardiomyocytes as background (those 
genes having a UMI count >1). To perform the Gene Ontology analysis 
on the vascular cells, the top 500 significant DEGs (P < 1 × 10−5) with a 
log-transformed fold change > 1 were searched against the Gene Ontol-
ogy biological process database using ToppFun79 (Supplementary 
Table 25). The top five significantly enriched terms (q < 0.05) for each 
subpopulation were selected and plotted on a heat map. To perform 
the pathway analysis on the adipocytes, the top 500 significant DEGs 
(P < 1 × 10−5) with a log-transformed fold change > 0.5 were searched 
against ToppFun79 pathway databases (Supplementary Table 26). The 
top five significantly enriched pathways (q < 0.05) for each subpopula-
tion were selected and plotted on a heat map.
Gene set score
We use the score_genes function as implemented in scanpy to calcu-
late the enrichment of genes involved in the Oncostatin M pathway. A 
list of genes was collected upon literature research88,89. For gene set 
enrichment, only highly expressed genes were considered to reduce 
noise (more than 500 UMIs across all cells). The same analysis was per-
formed for comparison of cardiac immune cells in our study with the 
observations of previous studies on cardiac-resident macrophages51, 
mouse tissue-remodelling macrophage45 and yolk sac lineage origin90.
Statistics and reproducibility
All analyses were performed using R Software, v.3.6.1. Student’s t-tests 
were used to compare cell type distributions at each site. P < 0.05 was 
considered statistically significant. Linear regression models (corre-
lations) were obtained using the R linear model function (lm), which 
estimates statistical likelihood (P value) of a linear relationship. Bonfer-
roni correction was applied for multiple testing.
The depicted RNAscope micrographs in the figures are representa-
tive. The micrographs in Figs. 2g, 3c, h and Extended Data Fig. 3c 
(HAMP), Extended Data Fig. 3e (CNN1), Extended Data Figs. 4g, m, 6f 
were repeated with similar results in two individual tissue sections. The 
micrographs in Figs. 2h, 3f and Extended Data Fig. 3c (CNN1), Extended 
Data Fig. 3e (PCDH7), Extended Data Figs. 6e, h, 9d were repeated with 
similar results in three individual tissue sections. The micrographs in 
Figs. 1e, 2d, 3e and Extended Data Figs. 1f, 3c (FHL1) and Extended Data 
Fig. 6d were repeated with similar results in four individual tissue sec-
tions. The micrographs in Fig. 2c and Extended Data Fig. 3c (PRELID2), 
Extended Data Figs. 10e, 12a were repeated with similar results in six 
or more individual tissue sections. Positive and negative controls were 
done once per used samples.
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GWAS enrichment analysis
We downloaded GWAS summary statistics from broad cvdi, EBI GWAS 
catalogue and GWAS atlas. We selected traits with well-powered 
GWAS (n > 5,000 and number of significant loci >10). GWAS data-
sets are summarized in Supplementary Table 27. Gene expression 
data of protein-coding genes were mapped onto Entrez gene ids and 
these gene annotations were used on the human genome assembly 
hg19/37. We only used gene expression data from nuclei. We imple-
mented the analysis previously described64 in python and in R. The 
log-transformed counts (plus one pseudocount) were used to com-
pute average cell type-specific expression profiles. We performed 
individual magma analyses for each cell type, always conditioning on 
default gene level covariates (for example, gene length) and average 
gene expression across all cells. Subsequently, we applied the Benja-
mini–Hochberg method and selected cell type trait associations with 
FDR < 10%. These pairs were then subjected to conditional analysis 
as previously described64 to define ‘independent’, ‘jointly explained’ 
and ‘partially jointly explained’ pairs of associations (Supplementary 
Table 28).
Distributions of dispersed cells and isolated nuclei
The different procedures for obtaining isolated nuclei and dispersed 
cells resulted in significantly different distributions of cell types (Sup-
plementary Table 29, Extended Data Fig. 2). Notably, 30.1% and 49.2% of 
isolated nuclei were derived from atrial and ventricular cardiomyocytes 
in the atrial and ventricular regions, whereas these cells were mostly 
excluded from preparations of isolated and CD45-selected cells (Sup-
plementary Table 2).
Excluding cardiomyocytes, the distribution of cell types identified 
from isolated nuclei and dispersed cells remained distinct (Supplemen-
tary Table 30). Although 59.0% of dispersed cells were ECs, only 15.7% 
of nuclei were derived from ECs. By contrast, 64.2% of nuclei were from 
FBs (31.2%) and pericytes (33.0%), whereas only 17.1% of dispersed cells 
were FBs (2.3%) and pericytes (14.8%). These differences may reflect 
sensitivity of EC nuclei to isolation procedures or resistance of pericytes 
and FBs to cellular enzymatic digestion.
Despite differences in cell distributions between isolated nuclei 
and dispersed cells, the gene expression profiles of cell lineages were 
reasonably correlated (r > 0.4 for each cell type). To address the con-
cordance of the genes captured by cells and nuclei, we compared the 
expression of the major cell type markers from Fig. 1c across the three 
sources (Extended Data Fig. 1c). As nuclei lack cytoplasmic RNA, the 
expression of certain genes, especially immune genes NKG7 and C1QA, 
was lower in nuclei than in cells. Nevertheless, the general trend with 
respect to marker genes was consistent across the three sources, and 
the same genes distinguished individual cell types independent of 
the source.
Further analysis of vascular cells
The PC3_str contained similar contribution of cells and nuclei, and had 
a scrublet score below the stringent threshold used; nevertheless, the 
average number of genes and counts in this cluster was higher than aver-
age. Thus, despite our stringent quality filtering, we cannot exclude the 
possibility that there might be doublets in this cluster. EC10_CMC-like 
and PC4_CMC-like co-express EC or pericyte genes with cardiomyocyte 
markers and further studies are required to understand whether they 
represent previously unknown cell states or doublets.
The observations of the arterial and venous SMC are supported by 
previous studies, which predict that arterial SMCs are more contractile, 
and venous SMCs are less differentiated91.
EC3_cap enrich for transcripts encoding components of AP1 (JUN and 
FOS), which mediates multiple EC fate decisions including response to 
VEGF, inflammatory and stress signals, and ATF3, an adaptive-response 
gene induced by diverse signals92–94.
Skeletal muscle characterization
We collected intercostal skeletal muscle samples from five healthy 
individuals, including one donor with matched cardiac tissue, and pro-
filed the transcriptome of 35,665 single cells and 39,597 single nuclei. 
Analogous to the heart, the combination of cells and nuclei allowed us 
to capture and resolve major cell lineages, including cardiomyocyte, 
fibroblasts, endothelial cells, smooth muscle cells, pericytes, myeloid 
and lymphoid immune cells and satellite cells (Extended Data Fig. 11a, 
b, Supplementary Table 31).
Further analysis of the vascular cells of the skeletal muscle identified 
ten distinct populations. The endothelial cells showed five clusters 
separated based on their respective vascular beds with signatures 
similar to the ones we observe in the heart. The EC_cap expresses VWF 
and RGCC. Venous EC_ven express ACKR1 and PLVAP, whereas arterial 
EC_art show SEMA3G and HEY1, in line with our heart data (Extended 
Data Fig. 11c, d, Supplementary Table 32).
The overall distributions of vascular and stromal cell populations 
in skeletal and cardiac muscle were similar, including the arterial and 
venous features of ECs; however; skeletal muscle contained a single 
SMC cluster, potentially related to the smaller size of the dataset. In 
skeletal muscle, the predicted cell–cell interactions of the EC_art and 
SMCs included NOTCH1/4–JAG1 as well as JAG1/JAG2/DLL4–NOTCH3, 
but not JAG1/JAG2/DLL4–NOTCH2, inferred in the heart (Extended 
Data Fig. 11e, f, Supplementary Table 33).
Cardiac immune cells
Using the logistic regression model, we did not identify any counterpart 
of the cardiac IL17RA+ monocytes in SKM or kidney, possibly owing to 
the small size of this population.
Naive T cells (CD4+T_naive) identified expressed CCR7 and SELL, 
indicative of their naive and tissue-resident nature95. Memory T cells 
(CD8+T_tem) expressed BACH2, STAT4 and IL7R, associated with 
long-term immune memory96,97. We further characterized the lym-
phoid cells using scNym98, and trained it using published data99,100. 
The resulting model was applied to our cardiac immune cells and 
those cells, with a predicted score higher than 0.8 were presumed 
to be likely candidates for re-annotation. Using this approach, we 
identified candidates for plasma B cells (109), dendritic cells (645), 
innate lymphoid cells (89), MAIT T cells (219), T helper cells (80) 
T regulatory cells (11), T central memory cells (103), γδ T cells (30) and 
plasmocytoid dendritic cells (27). These annotations can be found in 
the cardiac immune object annotations under the label ‘scNym’ at 
www.heartcellatlas.org.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
Data objects with the raw counts matrices and annotation are avail-
able via the www.heartcellatlas.org webportal. Raw data are available 
through the Human Cell Atlas (HCA) Data Coordination Platform 
(DCP) with accession number: ERP123138 (https://www.ebi.ac.uk/ena/
browser/view/ERP123138). The 10X Genomics Visium data for the heart 
left ventricle tissue can be accessed at: https://support.10xgenomics.
com/spatial-gene-expression/datasets/1.1.0/V1_Human_Heart. GWAS 
data used in this study can be found in Supplementary Table 27. All of 
our data can be explored at www.heartcellatlas.org.
Code availability
All code used for this study can be accessed as Jupyter notebooks in 
the project GitHub repository: https://github.com/cartal/HCA_Heart.
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Extended Data Fig. 1 | Expression of the canonical markers. a, UMAP 
embedding of selected canonical markers shown in Fig. 1c. b, Scaled expression 
(log2-transformed fold change, log2FC) of selected canonical markers shown in 
Fig. 1c. c, Expression (log2FC) of marker genes from Fig. 1c in each source 
highlighting that the same marker genes are used for identification of the same 
cell types in both cells and nuclei. d, Multiplexed smFISH staining of cell 
type-specific transcripts from Fig. 1e in right ventricles (top): TTN (green, 
cardiomyocytes) and CDH5 (red, EC) right atrium (middle): NPPA (green, aCM) 
and DCN (red, FB) and LA (bottom): MYH11 (green, SMC) and KCNJ8 (red, 
pericytes), nuclei are DAPI-stained (dark blue). Scale bars, 20 μm. For details on 
statistics and reproducibility, see Methods.
Extended Data Fig. 2 | Source and region covariates of the global dataset.  
a, UMAP embedding of the major cell types coloured by source. b, UMAP 
embedding highlighting the individual sources c, Distribution of cell types 
obtained by each source. Data are available in Supplementary Table 29. Further 
analyses and descriptions are available in the Methods and Supplementary 
Table 30. d, UMAP embedding of the major cell types coloured by region.  
e, UMAP embedding highlighting the individual regions f, Distribution of cell 
types across the six sampled regions (nuclei only). Data are available in 
Supplementary Table 2.
Article
Extended Data Fig. 3 | See next page for caption.
Extended Data Fig. 3 | Ventricular and atrial cardiomyocytes. a, Expression 
(log2FC) of selected marker genes in ventricular cardiomyocyte 
subpopulations. b, Expression (log2FC) of selected marker genes in atrial 
cardiomyocyte subpopulations c, Single channel multiplexed smFISH images 
of overlay shown in Fig. 2c, d, g, h. d, Expression (log2FC) of specific markers in 
cardiomyocyte subpopulations. I and II, PCDH7 expression in ventricular and 
atrial cardiomyocytes, respectively. III, PRELID2 expression is highest in vCM2 
and is enriched in right ventricles. IV and V, CNN1 expression is enriched in both 
vCM3 and aCM3. VI and VII, HAMP expression is enriched in the right atrium.  
e, Multiplexed smFISH of transcripts enriched in cardiomyocyte 
subpopulations. Left, expression of TNNT2 (green) and PCDH7 (red) in left 
ventricles. Right, expression of TNNT2 (green) and CNN1 (red) in right 
ventricles, nuclei are DAPI-stained (dark blue). Scale bars, 10 μm. f, Gene 
Ontology analysis results for vCM4 showing significant terms related to energy 
metabolism and muscle contraction. Data are available in Supplementary 
Table 6. g, Multiplexed smFISH of positive and negative RNAscope control 
probes. Scale bars, 5 μm. For details on statistics and reproducibility, 
see Methods.
Article
Extended Data Fig. 4 | See next page for caption.
Extended Data Fig. 4 | Vascular and mesothelial populations. a, Scaled 
expression (log2FC) of selected marker genes for EC subpopulations.  
b, c, Distribution of the EC subpopulations across the sources (b) and the 
regions (c) (nuclei only). Data are available in Supplementary Table 9. d, Scaled 
expression (log2FC) of selected marker genes of pericytes and smooth  
muscle cell subpopulations. e, f, Distribution of the mural subpopulations 
across the sources (e) and the regions (f) (nuclei only). Data are available in 
Supplementary Table 9. g, Multiplexed smFISH in apex section shows MYH11 
(yellow) expression in vascular SMC (thick in artery and very thin in nearby 
small calibre vein), CDH5 (red) in the endothelium, and SEMA3G (cyan) and 
ACKR1 (green) expression respectively in arterial and venous ECs, nuclei are 
DAPI-stained (dark blue). Scale bars, 20 μm. h, UMAP embedding of vascular 
and mesothelial cells with stochastic representation of the RNA velocity.  
i, Latent time of the vascular cells showing predicted directionalities of the cell 
populations based on the RNA splicing dynamics. The analysis uses only cells, 
nuclei are omitted. EC_cap, capillary ECs; EC_art, arterial ECs; EC_ven, venous 
ECs; EC atrial, atrial endothelial cells; EC_ln, lymphatic endothelial cells; 
PC, pericytes; PC_str, stromal pericytes; SMC_basic, smooth muscle cells; 
SMC_art, arterial smooth muscle cells. j, Predicted cell–cell interactions using 
the CellphoneDB statistical inference framework on 39,000 cells from 14 
biologically independent individuals (n = 14). Selected ligand–receptor 
interactions show specificity of NOTCH ligands-receptors pairing in defined 
vasculature beds. Mean of combined gene expression of interacting pairs 
(log2FC). CellPhoneDB P value of the specificity of the interactions = 10 × 10−5. 
The red rectangles highlight the arterial interactions and the blue rectangle 
highlights venous interactions depicted in Fig. 3d. Notably, even though the 
EC6_ven and SMC2_art interaction is unexpected, we cannot exclude that those 
cell states are restricted to their respective vascular beds. Further validation is 
needed to determine the exact spatial distribution of EC6_ven and SMC2_art 
and subsequently verify whether the interaction is plausible in vivo. Data are 
available in Supplementary Table 10. k, Scaled expression (log2FC) of the 
ligands and receptors from g across the vascular populations described in 
Fig. 3a. l, Scaled expression (log2FC) of selected marker genes of mesothelial 
cells. m, Multiplexed smFISH localizes the mesothelial cells expressing BNC1 
into the epicardium of the left atria. CDH5 shows endothelial cells in the tissue 
and is absent from the mesothelial cells, nuclei are DAPI-stained (dark blue). 
Scale bars, 20 μm. n, Distribution of the mural subpopulations across the 
sampled regions (nuclei only). Data are available in Supplementary Table 9. For 
details on statistics and reproducibility, see Methods.
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Extended Data Fig. 5 | Vascular markers visualized on 10X Genomics Visium 
data. a–d, Spatial expression (log2FC) of CDH5 (pan-EC marker), SEMA3G and 
GJA5 (arterial EC markers) (a), ACKR1 and PLVAP (venous EC markers) (b), MYH11 
and ACTA2 (pan-SMC markers) (c), and JAG1 and NOTCH2 (d) on publicly 
available 10X Visium section of human left ventricle. JAG1 and NOTCH2 are the 
predicted interaction partners for arterial ECs and SMCs, respectively.
Extended Data Fig. 6 | See next page for caption.
Article
Extended Data Fig. 6 | Fibroblasts. a, Scaled expression (log2FC) of selected 
marker genes of identified FB populations. b, Enrichment for oncostatin M 
pathway for FB populations showing enriched activity in FB3. A list of genes 
with which the score was calculated is in Supplementary Table 12. c, Regional 
distribution per FB population. Some FB populations show enrichment in the 
atria (left and right), such as FB2 and FB3. FB1, FB4–FB6 are enriched in the 
ventricles (left, right, apex and interventricular septum). Data are available in 
Supplementary Table 35. d–f, Multiplexed smFISH for probes targeting FAP, 
LINC01133 and PTX3 confirming FB4, FB5 and FB3 subpopulations. FAP (red) is 
imaged in interventricular septum, LINC01133 (red) in apex and PTX3 (red) in 
right atrium tissue section. DCN (cyan) is used as a pan-FB marker, C1QA (green) 
as a pan-macrophage marker, nuclei are DAPI-stained (dark blue). Scale bars, 
5 μm. g. Scaled expression (log2FC) of APOD and CFH genes, which represent 
differences between ventricular and atrial fibroblasts. h, Multiplexed smFISH 
of apex section representing DCN (cyan), APOD (red) and CFH (green), nuclei 
are DAPI-stained (dark blue). Although the APOD signal colocalized with DCN, 
expression of CFH was absent. Scale bars, 5 μm. i, UMAP embedding of the 
ventricular fibroblast cell-states. j, UMAP embedding of atrial fibroblasts cell 
types. k, Scaled expression (log2FC) of marker genes for ventricular fibroblast 
subpopulations. l, Scaled expression (log2FC) of marker genes for atrial 
fibroblast subpopulations. m, Scaled expression (log2FC) of ECM genes 
differentiating atrial (aFB1, aFB2) and ventricular (vFB2, vFB4) clusters which 
suggest different ECM mechanisms. For details on statistics and 
reproducibility, see Methods.
Extended Data Fig. 7 | Covariates of immune cardiac populations.  
a–j, UMAP embedding of cell source (a), donor (b), gender (c), type (d), number 
of genes (e), number of counts (f), percentage of mitochondrial genes (g), 
percentage of ribosomal genes (h), scrublet score (i) and annotation of the cell 
populations of the immune cells ( j).
Article
Extended Data Fig. 8 | See next page for caption.
Extended Data Fig. 8 | Immune cardiac populations. a, Visualization of 
transcriptional signatures from published studies. The score values represent 
the likelihood of the external transcriptional signature to be present when 
comparing it against the transcriptional background of a cardiac immune 
population. Bajpai_2018 = CCR2-MERTK+ tissue-resident macrophages from  
ref. 51. Dick_2019 = self-renewing tissue macrophages from ref. 45. Bian_2020 = yolk 
sac-derived macrophages from ref. 90. The complete signature can be found in 
Supplementary Table 19. b, Expression (log2FC) of LYVE1, FOLR2 and TIMD4 
characteristic of the self-renewing tissue-resident murine macrophages 
previously described45, as well as MERTK as previously described51 and the 
TREM2 expression associated to lipid-associated macrophages (LAM) 
previously described46. Complete signatures can be found in Supplementary 
Table 19. c, Scaled expression (log2FC) of genes differentiating DOCK4+ MP1 
from DOCK4+ MP2: IL4R, ITGAM, STAT3, DOCK1, HIF1A and RASA2. d, Predicted 
cell–cell interactions calculated for 69,295 cardiomyocytes, fibroblasts and 
myeloid cells from 14 donors (n = 14) and enriched for ‘extracellular matrix 
organization’. Mean of combined gene expression of interacting pairs (log2FC). 
Data are available in Supplementary Table 17. e, Spatial mapping of the CD74–
MIF interaction between LYVE1+MP and FB4 on a publicly available 10X 
Genomics Visium dataset for left ventricular myocardium. We identified four 
spots where we observe co-expression of FN1, LYVE1, CD74 and MIF, as predicted 
from the cell–cell interactions. The bar represents the log2FC. f, Confusion 
matrix for the logistic regression model trained on cardiac immune cells. This 
model reached an accuracy score of 0.6862, showing a stronger accuracy with 
lymphoid cells, compared with the myeloid ones.
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Extended Data Fig. 9 | See next page for caption.
Extended Data Fig. 9 | Neuronal and adipocyte populations. a, UMAP 
embedding identifies six neuronal subpopulations. b, Regional distribution of 
neuronal cell subpopulations identified in a. Data are available in 
Supplementary Table 20. c, Expression (log2FC) dot plot of selected marker 
genes in neuronal cell subpopulations. d, Multiplexed smFISH of NRXN1 
(green) and PPP2R2B (red), nuclei were DAPI-stained (dark blue). Scale bars,  
5 μm. For details on statistics and reproducibility, see Methods. e, UMAP 
embedding showing four adipocyte subpopulations. f, UMAP embedding of 
expression of gene markers associated with adipocytes (GPAM, FASN, ADIPOQ, 
LEP). g, Top five significantly enriched pathways for each adipocyte 
subpopulation, using differentially expressed genes calculated using the 
Wilcoxon rank sum test with Benjamini–Hochberg correction (logFC >0.5, 
P < 1.0 × 10−5) and tested using a hypergeometric distribution with Bonferroni 
correction as implemented in ToppFun. Data are available in Supplementary 
Table 21. h, Expression (log2FC) of adipocyte associated genes and select 
marker genes from the top enriched pathway for each adipocyte 
subpopulation.
Article
Extended Data Fig. 10 | See next page for caption.
Extended Data Fig. 10 | Relevance for COVID-19 and GWAS studies. a, Global 
expression (log2FC) of ACE2 in all cardiac cells. b–d, Gene expression of ACE2, 
TMPRSS2, CTSB and CTSL in cardiomyocytes (b), FBs (c) and vascular cells (d).  
e, Multiplexed smFISH expression of DCN (cyan), KCNJ8 (green) and ACE2 (red), 
nuclei are DAPI-stained (dark blue) marking fibroblasts (#; expression of DCN) 
and pericytes (*; co-expression of DCN and KCNJ8) in right ventricular tissue 
section. Scale bars, 5 μm. For statistics and reproducibility, see Methods. f, The 
colour coding of the heat map shows the −log10(P value) of the MAGMA GWAS 
enrichment analysis for the association between cell type-specific expression 
( y axis) and GWAS signals (x axis). The cell types refer to the subcluster 
annotations and GWAS studies refer to Supplementary Table 27. AF, atrial 
fibrillation; CAD, coronary artery disease; HF, heart failure; HR, heart rate; HT, 
hypertension; LVD, left ventricular diameter; NICM, non-ischaemic 
cardiomyopathy; PR, PR interval; PWAVE, P-wave duration; T2D, type 2 
diabetes; QRS, QRS complex duration; QT, QT interval. Dots mark significant 
associations (FDR < 10%). The colour of the dots indicates the type of 
association as determined by pairwise conditional analysis (green: 
independent association, blue: partially jointly explained with other cell types, 
grey: explained away by other cell types). Data are available in Supplementary 
Table 28.
Article
Extended Data Fig. 11 | See next page for caption.
Extended Data Fig. 11 | Skeletal muscle populations. a, UMAP embedding of 
transcriptional data from skeletal muscle using cells and nuclei. 
Mural, pericytes and smooth muscle cells. b, Scaled expression (log2FC) of 
selected markers for the major skeletal muscle populations. c, UMAP 
embedding of vascular and stromal populations of skeletal muscle. d, Scaled 
expression (log2FC) of marker genes used in Extended Data Fig. 3 for 
identification of vascular cell states. e, Predicted cell–cell interactions inferred 
using CellphoneDB statistical inference framework in skeletal muscle cells with 
9,220 cells from five donors (n = 5) depicting cell states from c, Selected ligand–
receptor interactions show specificity of NOTCH ligand–receptor pairing in 
defined vasculature beds. The interactions of EC_art-SMC are highlighted by a 
red rectangle and EC_ven-SMC are highlighted by a blue rectangle. Colour of 
the dots indicates the mean expression level of interacting molecule in partner 
1 and interacting molecule partner 2. Mean of combined gene expression of 
interacting pairs (log2FC). CellPhoneDB P value of the specificity of the 
interactions = 10 × 10−5. Data are available in Supplementary Table 10. f, Scaled 
expression (log2FC) of the ligands and receptors from Extended Data Fig. 3 
depicted on vascular populations of skeletal muscle.
Article
Extended Data Fig. 12 | Analysis technical information. a, Locations and 
representative histology section of six cardiac regions sampled, including 
right and left atrium, right and left ventricular free wall and left ventricular 
apex and interventricular septum. H&E, magnification ×10; scale bars, 500 μm. 
b, Spatial visualization of positive and negative RNAscope control probes. 
Scale bars, 5 μm. For statistics and reproducibility, see Methods. c, Heat map of 
top five significantly enriched Gene Ontology Biological Processes term for 
each of the vascular subpopulations from Fig. 3a. Data are available in 
Supplementary Table 25. d, SCCAF scores for each batch aligned manifold. For 
each population, we plotted the true positive (TPR) versus false positive (FPR) 
learning ratios from the subpopulation in each manifold. Next, we plotted how 
accurately the manifold represents each learned subpopulation based on the 
test training set and the CV cross-validation set. The closer the CV value to the 
test value, the better the manifold is at representing the subpopulations.
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For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
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Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection Software used include: BD FACS Sortware 1.2.0.142 (BD Influx), Summit V5.4.0.16584 (BD XDP), BD FACSDIVA 6.1.3 (Aria), Axiovision 4.9.1 and 
ZEN 2.3 software (Zeiss), Harmony 4.9 (Perkin Elmer), Chromium Controller Firmware version 5.00 (10X Genomics).
Data analysis Software used include: R 3.6, Python 3.7, 10X Genomics’ Cell Ranger 3.0.2, Harmony 4.9 (Perkin Elmer), Axiovision 4.9.1 and ZEN 2.3 (Zeiss), 
Adobe Illustrator 24.2.3, CorelDraw X4, 10X Genomics' Space Ranger 1.0.0, ImageJ 1.52Q or 1.52P, Scanpy 1.4, bbknn 1.3.11, scGen 6c237d7, 
anndata 1.7, pandas 1.0.1, numpy 1.19, scVelo 1d87464. 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and 
reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The data is made available through the Human Cell Atlas (HCA) Data Coordination Platform (DCP) and can be accessed here: https://www.ebi.ac.uk/ena/browser/
view/ERP123138. The data can also be accessed and explored through the HCA Heart Project website at www.heartcellatlas.org. 
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No sample-size calculation was done due to the nature of this study. 
Non-failing hearts were collected from human donors from July 2018 to July 2019 on the basis of availability from CBTM (Cambridge, UK) and 
The University of Alberta (Canada). Our study explores the cellular composition of the healthy adult human heart and we state that the 
number of samples is not enough to make generalisations. 
Data exclusions No data were excluded from the analysis. For the final count matrix, we excluded cells based on pre-established criteria for single-cells: we 
excluded low quality samples and contaminating cells (i.e. - cells with low number of detected genes and high mitochondria content).
Replication We performed single nuclei RNAseq on 14 hearts (4 - 6 regions each) and single cell RNAseq on 7 hearts (4 - 6 regions each), with comparable 
results among all the donors. The same samples were used for the validation experiments. The micrographs in Figure 2g,  3c/h and Extended 
Data Figure 2c (HAMP), 2e (CNN1), 3f, 3k, 4f are repeated with similar results in 2 individual tissue sections. The micrographs in Figure 2h, 3f 
and Extended Data Figure 2c (CNN1), 2e (PCDH7), 4e, 4h, 6d are repeated with similar results in 3 individual tissue sections. The micrographs 
in Figure 1e, 2d, 3e, and Extended Data Figure 1f, 2c (FHL1) and 4d are repeated with similar results in 4 individual tissue sections. The 
micrographs in Figure 2c and Extended Data Figure 2c (PRELID2), 7e, 9a are repeated with similar results in 6 or more individual tissue 
sections. Positive and negative controls were done once per used samples. 
 
For skeletal muscle analysis, single cells and single nuclei were isolated from 5 individuals, with comparable results among all the donors. 
Randomization Only healthy individuals were considered in our analysis. Randomisation was not relevant due to the study design where non-failing hearts 
were used on availability.
Blinding Only healthy individuals were considered in our analysis. Blinding was not relevant due to the study design where non-failing hearts were used 
on availability, and the analytical strategy would not benefit from it.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
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Animals and other organisms
Human research participants
Clinical data
Dual use research of concern
Methods





Antibodies used anti-human CD45 monoclonal antibody-conjugated microbeads (Miltenyi Biotec, 130-045-801) in dilution 1:4 (20 ul of antibody-
labeled microbeads in 80 ul of cell suspension buffer).
Validation Commercially available product, full protocol and validation available at miltenyibiotec.com/_Resources/
Persistent/25cf8ecca93dc183f1d96d5348e58ca0e9a07c40/DS130-045-801.pdf
Human research participants
Policy information about studies involving human research participants
Population characteristics Tissues were obtained form 14 individuals, eight (D1-7 and 11) collected in the United Kingdom and six (H2-7) collected in 
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Population characteristics North America. The cohort consisted of seven male (D2, D3, D6, D7, H2, H3 and H4) and seven female (D1, D4, D5, D11, H5, 
H6 and H7) donors, in the range of 40-75 years of age. Six of the donors were classified as DCD (Donation after Circulatory 
Death, D2, D4-7 and D11) and eight donors were classified as DBD (Donation after Brain Death, D1, D3, H2-7). 
Recruitment Cardiovascular history was unremarkable for all donors, and this was the main recruitment criteria used for to include 
individuals in our study. We believe this method of recruitment does not represent any bias that can impact our results. 
Ethics oversight Heart tissues (D1-7 and 11) were obtained from deceased transplant organ donors after Research Ethics Committee approval 
(Ref 15/EE/0152, East of England - Cambridge South Research Ethics Committee) and informed consent from the donor 
families.  
 
Heart tissues (H2-7) were obtained from deceased organ donors after Human Research Ethics Board approval Pro00011739 
(University of Alberta, Edmonton, Canada). Informed consent from donor families was acquired via the institutional Human 
Organ Procurement and Exchange Program (HOPE).




The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation As described in the Methods section. Briefly, the single nuclei were isolated by mechanical homogenisation and 
washed. The nuclei were stained with commercially available Hoechst 33342 dye (NucBlue , R376050). The samples were 
kept on ice and directly loaded onto the FACS-sorter.
Instrument Becton Dickinson (BD) Influx, XDP, or FACSAria
Software Proprietary software of the selected sorter.
Cell population abundance N/A
Gating strategy Single nuclei were selected for single signal on the SCC and FCC to avoid aggregates. The Hoechst-positive nuclei were 
selected without any size limit. The gating strategy is available as Supplementary Figure 1. 
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
